Viewing Study NCT00728351


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-01-24 @ 10:21 AM
Study NCT ID: NCT00728351
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2008-07-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes, vildagliptin View